Viewing Study NCT02807233


Ignite Creation Date: 2025-12-25 @ 2:52 AM
Ignite Modification Date: 2026-03-14 @ 4:21 PM
Study NCT ID: NCT02807233
Status: COMPLETED
Last Update Posted: 2019-08-05
First Post: 2016-05-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects
Sponsor: Ipsen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acromegaly View
Keywords: